Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus (T2DM) is a major risk factor for pulmonary tuberculosis (PTB); it exacerbates disease severity and reduces the efficacy of anti-tuberculosis therapy. However, systemic metabolic interactions between PTB and T2DM during treatment remain unclear.
No takes yet. Share an insight, caveat, or question.
何祚宽(Zuokuan He) (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: